Mark Landers

2.0k total citations · 1 hit paper
42 papers, 1.6k citations indexed

About

Mark Landers is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Landers has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Landers's work include Cancer Genomics and Diagnostics (22 papers), Cancer Cells and Metastasis (16 papers) and Prostate Cancer Treatment and Research (14 papers). Mark Landers is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Cancer Cells and Metastasis (16 papers) and Prostate Cancer Treatment and Research (14 papers). Mark Landers collaborates with scholars based in United States, United Kingdom and China. Mark Landers's co-authors include Andrew Scott, Evgeny Kobrinsky, Elena Ondriašová, Maria C. Moschella, Thottala Jayaraman, Karol Ondriaš, Andrew R. Marks, Barbara E. Ehrlich, Ryan Dittamore and Ryon P. Graf and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Mark Landers

40 papers receiving 1.6k citations

Hit Papers

Stabilization of calcium release channel (ryanodine recep... 1994 2026 2004 2015 1994 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
    1994 679 citations Karol Ondriaš, Andrew Scott et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Landers United States 15 1.0k 447 400 311 279 42 1.6k
Leomar Y. Ballester United States 29 752 0.7× 273 0.6× 449 1.1× 413 1.3× 173 0.6× 108 1.9k
Dilek Çolak Saudi Arabia 25 1.2k 1.1× 512 1.1× 292 0.7× 162 0.5× 94 0.3× 101 2.2k
Gentzon Hall United States 21 782 0.8× 347 0.8× 252 0.6× 130 0.4× 281 1.0× 45 1.9k
Naoki Kimura Japan 21 1.6k 1.5× 298 0.7× 263 0.7× 128 0.4× 46 0.2× 65 2.5k
Masanori Nakayama Japan 23 2.1k 2.0× 449 1.0× 308 0.8× 179 0.6× 175 0.6× 51 3.7k
Seiichiro Nishimura Japan 21 1.4k 1.4× 170 0.4× 274 0.7× 78 0.3× 569 2.0× 64 2.0k
Daniela Panáková Germany 20 1.7k 1.6× 88 0.2× 142 0.4× 163 0.5× 412 1.5× 30 2.2k
David J. Kwiatkowski United States 12 951 0.9× 165 0.4× 106 0.3× 122 0.4× 154 0.6× 14 1.7k
Bingying Zhou China 22 1.5k 1.5× 156 0.3× 285 0.7× 134 0.4× 326 1.2× 46 2.1k
Lucrezia Fontana Italy 8 1.4k 1.4× 158 0.4× 1.4k 3.4× 141 0.5× 158 0.6× 9 2.2k

Countries citing papers authored by Mark Landers

Since Specialization
Citations

This map shows the geographic impact of Mark Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Landers more than expected).

Fields of papers citing papers by Mark Landers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Landers. The network helps show where Mark Landers may publish in the future.

Co-authorship network of co-authors of Mark Landers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Landers. A scholar is included among the top collaborators of Mark Landers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Landers. Mark Landers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Shan, Chia-Jung Chang, Yinghui Guan, et al.. (2020). Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level. Journal of Molecular Diagnostics. 22(6). 770–781. 24 indexed citations
2.
Anderson, Amanda, et al.. (2019). CTC enumeration and characterization as a pharmacodynamic marker in the phase I clinical study of APX3330, an APE1/Ref-1 inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 37(15_suppl). e14531–e14531. 9 indexed citations
3.
Vansant, Gordon, Adam Jendrisak, Joseph D. Schonhoft, et al.. (2018). Analysis of circulating tumor cells (CTCs) in patients across multiple metastatic breast cancer (mBCa) cohorts identifies marked inter- and intra-patient heterogeneity in CTC size, shape, and overall morphology.. Journal of Clinical Oncology. 36(15_suppl). 1084–1084. 2 indexed citations
4.
Boffa, Daniel J., Ryon P. Graf, Michelle C. Salazar, et al.. (2017). Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1139–1145. 61 indexed citations
5.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2017). Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer. Cancer Research. 77(20). 5687–5698. 94 indexed citations
6.
O’Shannessy, Daniel J., Charles Schweizer, Wenquan Wang, et al.. (2017). Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer. Genomics. 109(3-4). 251–257. 15 indexed citations
7.
Wang, Yipeng, Stephanie Greene, Ángel Rodríguez, et al.. (2016). The use of whole genome copy number variation (CNV) to measure genomic instability in mCRPC CTCs.. Journal of Clinical Oncology. 34(2_suppl). 307–307. 2 indexed citations
8.
Greene, Stephanie, Angel E. Dago, Yipeng Wang, et al.. (2016). Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis. PLoS ONE. 11(11). e0165089–e0165089. 37 indexed citations
9.
10.
O’Shannessy, Daniel J., Charles Schweizer, Wenquan Wang, et al.. (2016). Analysis of molecular and protein signatures on farletuzumab pharmacokinetics from a phase 3 ovarian cancer study.. Journal of Clinical Oncology. 34(15_suppl). e14508–e14508. 1 indexed citations
11.
Beltran, Himisha, Adam Jendrisak, Mark Landers, et al.. (2015). The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer. Clinical Cancer Research. 22(6). 1510–1519. 108 indexed citations
12.
Werner, Shannon L., Ryon P. Graf, Mark Landers, et al.. (2015). Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization. 4(1). 8 indexed citations
13.
Werner, Shannon L., Ryon P. Graf, Mark Landers, et al.. (2015). Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization. SHILAP Revista de lepidopterología. 4. 3–3. 100 indexed citations
14.
Lu, David, Ryon P. Graf, Melissa Harvey, et al.. (2015). Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells. PubMed. 4. 4–4. 8 indexed citations
15.
16.
Landers, Mark, et al.. (2013). ON001 An investigation of the manifestations of perceived psychological stress in patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 7. S295–S295. 1 indexed citations
17.
Lan, Xun, Christopher M. Adams, Mark Landers, et al.. (2011). High Resolution Detection and Analysis of CpG Dinucleotides Methylation Using MBD-Seq Technology. PLoS ONE. 6(7). e22226–e22226. 65 indexed citations
18.
Landers, Mark. (2005). Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans. Nucleic Acids Research. 33(13). 3976–3984. 47 indexed citations
19.
Landers, Mark. (2004). Regulation of the large ( 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Research. 32(11). 3480–3492. 128 indexed citations
20.
Ondriaš, Karol, Andrew Scott, Evgeny Kobrinsky, et al.. (1994). Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 77(4). 513–523. 679 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leomar Y. Ballester Breakdown of academic impact, for papers by Dilek Çolak Breakdown of academic impact, for papers by Gentzon Hall Breakdown of academic impact, for papers by Naoki Kimura Breakdown of academic impact, for papers by Masanori Nakayama Breakdown of academic impact, for papers by Seiichiro Nishimura Breakdown of academic impact, for papers by Daniela Panáková Breakdown of academic impact, for papers by David J. Kwiatkowski Breakdown of academic impact, for papers by Bingying Zhou Breakdown of academic impact, for papers by Lucrezia Fontana
Rankless by CCL
2026